Purchase Order HHSN271201500077A
Award Date 9/23/15
Potential Completion Date 9/30/16
Potential Value $156K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a firm fixed-price purchase order contract to Lavision Biotec GMBH, a for-profit manufacturer located in Germany. The contract, valued at $342,183.61, does not have a set-aside designation. The contract was awarded on August 19, 2016, with an ultimate completion date of October 30, 2016. No further details about the specific products or services being provided under this contract were included in the information...
- This federal contract award was granted by the National Institute on Drug Abuse (NIDA), a civilian agency, to Idea Bio-Medical LTD, a for-profit organization, on September 9, 2015. The contract has a firm fixed price of $122,500.00 and a completion date of October 30, 2015. No set-aside designation was used. The contract type is a purchase order and does not appear to be associated with a larger contract vehicle. The provided information does not indicate any major subcontractors or additional...
- <p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
- This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
- The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...
- <p>This is a $460,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Charles River Discovery Research Services UK LIMITED, a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a performance period ending on January 31, 2016. The contract does not have a set-aside designation.</p>
- This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
- <p>This is a $493,000.00 firm fixed price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Catalent Maryland, Inc. (doing business as Paragon Biosciences). The contract does not have a set-aside designation. The contract supports work related to NIDA's programs, with an ultimate completion date of September 27, 2017. Catalent Maryland, Inc. is the prime contractor for this award.</p>
- The federal contract award is for the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to procure supplies from Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific equipment and software. The $16,287.50 firm fixed price purchase order is to provide the laboratory members of NIDA researcher Leandro Vendruscolo with items needed to perform experiments involving alcohol and opioids in mice and rats. The contract does not have a set-aside...
- The U.S. National Institute on Drug Abuse (NIDA) has awarded a firm-fixed-price purchase order contract worth $20,217.10 to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract, which does not have a set-aside designation, is for the provision of various research and development services to support NIDA's drug abuse research programs. These services include receptor binding studies, predictive toxicology, safety pharmacology, and non-clinical research....